Correlation Between Bank Central and Viaderma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank Central and Viaderma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Central and Viaderma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Central Asia and Viaderma, you can compare the effects of market volatilities on Bank Central and Viaderma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Central with a short position of Viaderma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Central and Viaderma.

Diversification Opportunities for Bank Central and Viaderma

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bank and Viaderma is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Bank Central Asia and Viaderma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viaderma and Bank Central is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Central Asia are associated (or correlated) with Viaderma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viaderma has no effect on the direction of Bank Central i.e., Bank Central and Viaderma go up and down completely randomly.

Pair Corralation between Bank Central and Viaderma

Assuming the 90 days horizon Bank Central is expected to generate 10.26 times less return on investment than Viaderma. But when comparing it to its historical volatility, Bank Central Asia is 7.72 times less risky than Viaderma. It trades about 0.03 of its potential returns per unit of risk. Viaderma is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1.30  in Viaderma on September 12, 2024 and sell it today you would lose (0.36) from holding Viaderma or give up 27.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bank Central Asia  vs.  Viaderma

 Performance 
       Timeline  
Bank Central Asia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bank Central Asia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Bank Central is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Viaderma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Viaderma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Viaderma displayed solid returns over the last few months and may actually be approaching a breakup point.

Bank Central and Viaderma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank Central and Viaderma

The main advantage of trading using opposite Bank Central and Viaderma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Central position performs unexpectedly, Viaderma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viaderma will offset losses from the drop in Viaderma's long position.
The idea behind Bank Central Asia and Viaderma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Transaction History
View history of all your transactions and understand their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like